These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 30810868)

  • 1. Comparative Analysis of Bioactivity of the Russian-Made Antitumor Substances of the Nitrosourea Group.
    Bunyatyan ND; Oborotova NA; Nikolaeva LL; Saprykina NS; Borisova LM; Kiseleva MP; Prokof'ev AB
    Bull Exp Biol Med; 2019 Feb; 166(4):456-460. PubMed ID: 30810868
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antitumor activity and toxicity of methyl 6-[3-(2-chloroethyl)- 3-nitrosoureido]-6-deoxy-alpha-D-glucopyranoside in experimental animals.
    Fujimoto S; Tashiro T; Ogawa M
    Gan; 1984 Oct; 75(10):937-46. PubMed ID: 6510639
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antitumor effects of GANU and other nitrosourea derivatives against transplantable leukemias and solid tumors in mice.
    Sava G; Giraldi T
    Cancer Chemother Pharmacol; 1983; 10(3):167-9. PubMed ID: 6222844
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of 1-(2-chloroethyl)-3-isobutyl-3-(beta-maltosyl)-1-nitrosourea on experimental tumors.
    Akaike Y; Arai Y; Taguchi H; Satoh H
    Gan; 1982 Jun; 73(3):480-7. PubMed ID: 7129012
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A new nitrosourea derivative TA-077, 1-(2-chloroethyl)-3-isobutyl-3-(beta-maltosyl)-1-nitrosourea. I. Comparative study on antitumor activity.
    Fujimoto S; Ogawa M
    Cancer Chemother Pharmacol; 1982; 9(3):134-9. PubMed ID: 6218931
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Letter: Antitumor activities of 3-(methyl-alpha-D-glucopyranos-2-yl)-1-(2-chloroethyl)-1-nitrosourea.
    Iwasaki M; Okawa H; Ninomiya K; Sekine J; Nagamatsu Y
    Gan; 1975 Jun; 66(3):347-8. PubMed ID: 1181236
    [No Abstract]   [Full Text] [Related]  

  • 7. Synthesis and antitumour activity of several new 4-aroyl-1-nitrosohydrazinecarboxamides.
    Gugova R; Topakbashian V; Lozeva S; Dimov S; Golovinsky E
    Drugs Exp Clin Res; 1997; 23(2):71-5. PubMed ID: 9309382
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antitumor activity of the novel nitrosourea S10036 in rodent tumors.
    Filippeschi S; Colombo T; Bassani D; De Francesco L; Arioli P; D'Incalci M; Bartosek I; Guaitani A
    Anticancer Res; 1988; 8(6):1351-4. PubMed ID: 3064716
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Experimental studies on oral administration of nitrosourea anti-tumor agent, MCNU].
    Sekido S; Ninomiya K; Araki T; Ueno M; Kinbara M
    Gan To Kagaku Ryoho; 1984 Jul; 11(7):1492-500. PubMed ID: 6234861
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic and diabetogenic potential of two newly synthesized nitrosoureido sugars.
    Bernacki RJ; Wilson GL; Mossman BT; Angelino N; Kanter PM; Korytnyk W
    Cancer Res; 1985 Feb; 45(2):695-702. PubMed ID: 3881170
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antitumor activity of a new fluoropyrimidine derivative, 5'-deoxy-5-fluorouridine, against murine and human experimental tumors.
    Fujimoto S; Wang Y; Inoue K; Ogawa M
    Jpn J Cancer Res; 1985 Jul; 76(7):644-50. PubMed ID: 3161854
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparison of a new nitrosourea derivative, 1-(2-chloroethyl)-3-isobutyl-3-(beta-maltosyl)-1-nitrosourea with various antitumor agents with respect to therapeutic ratios in L1210 leukemia systems.
    Fujimoto S; Ogawa M
    J Pharmacobiodyn; 1987 Jul; 10(7):341-5. PubMed ID: 3694427
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of 1-(2-chloroethyl)-3-(beta-D-glucopyranosyl)-1-nitrosourea on experimental tumors.
    Hisamatsu T; Uchida S
    Gan; 1977 Dec; 68(6):819-24. PubMed ID: 202535
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis of nitrosourea derivatives of sucrose as central nervous system anticancer agents.
    Almquist RG; Reist EJ
    J Med Chem; 1977 Oct; 20(10):1246-50. PubMed ID: 903916
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of 1,3,3,5,5-pentaziridino-1-thia-2,4,6-triaza-3,5-diphosphorine-1-oxide, a new antitumor agent with inorganic ring, on various experimental tumors.
    Kitazato K; Takeda S; Unemi N
    J Pharmacobiodyn; 1982 Oct; 5(10):803-10. PubMed ID: 7161708
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activity of SC33428, a novel bishydrazone-bridged derivative of 4-demethoxydaunorubicin, against experimental tumors in mice.
    Dawson KM
    Cancer Res; 1983 Jun; 43(6):2880-3. PubMed ID: 6573953
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potentiation of therapeutic effects of 3-[(4-amino-2-methyl-5-pyrimidinyl)methyl]-1-(2-chloroethyl)-1-nitrosourea hydrochloride by 6-thioguanine in mouse tumor systems: comparison with other antimetabolites.
    Fujimoto S; Ogawa M; Hoshino A
    Gan; 1980 Feb; 71(1):60-72. PubMed ID: 6929770
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In the search for new anticancer drugs, XXI. Spin labeled nitrosoureas.
    Sosnovsky G; Li SW; Rao NU
    Z Naturforsch C J Biosci; 1987; 42(7-8):921-31. PubMed ID: 2961152
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of solid tumors by nitrosoureas. 1. Lewis lung carcinoma.
    Montgomery JA; McCaleb GS; Johnston TP; Mayo JG; Laster WR
    J Med Chem; 1977 Feb; 20(2):291-5. PubMed ID: 836501
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biologic activity of MCNU: a new antitumor agent.
    Sekido S; Ninomiya K; Iwasaki M
    Cancer Treat Rep; 1979 Jun; 63(6):961-70. PubMed ID: 466655
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.